Article

Bbarrons.com on 2021-01-26 14:02

Novartis Warns Covid-19 Sales Impact Will Last Until Mid 2021

The Swiss pharmaceutical company’s stock slipped on Tuesday, as it offered cautious guidance.

Vas Narasimhan

Related news

BNovartis Stock Falls as Swiss Drugmaker Cuts Sales Outlook on Pandemic Woes barrons.com
Basel , Switzerland
BNovartis Has the Most Expensive Drug in the World. Sales Are Looking Strong.barrons.com
Switzerland
MNovartis profit misses forecasts, but sales beat marketwatch.com
Switzerland
Novartis notches higher profit on strong sales thelocal.ch
India , Switzerland
FNovartis faces possible S Korea sales ban ft.com
Switzerland , South Korea
Novartis Earnings Fall on Slide in Cancer-Drug Sales wsj.com
Switzerland
Novartis sales rise as clients restock post-lockdown timesofmalta.com
Malta , Switzerland
Novartis profit slips as generic drug competition hits sales The Findlay Courier
Switzerland
MNovartis net income climbs as drug sales grow marketwatch.com
France , Switzerland
HWHO: Widespread COVID Vaccinations Not Expected Until Mid-2021 hamodia.com
Switzerland , Canton of Geneva
Dollar General Warns of Slower Sales Growth wsj.com
Warns , Dollar General
BNovartis Stock Is Rising as Earnings Inch Past Forecasts barrons.com
Switzerland , Stock Island
South Korea fines Novartis over kickbacks, suspends sales of some drugs metro.us
Switzerland , South Korea
MNovartis sales and profit drop, but backs 2022 guidance1 min read marketwatch.com
Basel , Switzerland
Novartis net profit grows 10 percent in Q2, but sales dip kentucky.com
Switzerland
BNovartis Posts Strong Results, but Is Silent on Gene-Therapy Sales barrons.com
France , Wall Street , Switzerland
Chinese State Grid Warns of 'Power Shortages' Until Spring 2022 breitbart.com
Warns , China
MPernod Ricard warns about second COVID wave impact ahead marketwatch.com
Ireland , Europe , Paris , France
FNovartis faces vexing decisions over asset sales ft.com
South East Asia , China